文献速递认知障碍与痴呆

原发性进行性失语症中的脑微出血与脑脊液阿尔茨海默病生物标志物

Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias.
PubMed 文献 · Neurology · 2018-02-14

这项多中心横断面研究纳入82例原发性进行性失语症(PPA)患者和19例年龄相仿的健康对照,评估脑微出血(CMB)的患病率、定位及其与脑脊液阿尔茨海默病生物标志物的关系。结果显示PPA患者CMB患病率(28%)高于对照(16%),以logopenic型最高(50%),且脑脊液阿尔茨海默病生物标志物阳性者CMB更常见(67% vs 20%),但CMB与语言及认知损害无关。

要点

  • PPA患者脑微出血患病率(28%)高于健康对照(16%)。
  • logopenic型PPA脑微出血患病率(50%)高于semantic型(18%)和非流利/语法型(17%)。
  • 脑脊液阿尔茨海默病生物标志物阳性的PPA患者脑微出血更常见(67% vs 20%)。

核心结论

  • PPA患者脑微出血患病率高于健康对照,以logopenic型最常见,与潜在阿尔茨海默病理相关,且不影响语言/认知损害。
  • 作者认为MRI检测脑微出血有助于PPA变异型诊断,尤其是logopenic型PPA,并可提供潜在神经病理的估计。

研究设计与样本

  • 多中心横断面研究,纳入82例PPA患者和19例年龄相仿的健康对照。
  • MRI评估脑微出血(2维梯度回波T2*、磁敏感加权成像序列)和白质高信号。
  • 63例患者的脑脊液阿尔茨海默病生物标志物分析用于将PPA分为有或无 probable underlying Alzheimer pathology 的亚组。

主要发现

  • 脑微出血患病率在PPA患者为28%,在健康对照为16%。
  • 脑微出血患病率在logopenic型PPA为50%,在semantic型PPA为18%,在非流利/语法型PPA为17%。
  • 脑微出血定位主要为脑叶(81%),各PPA变异型间无差异。
  • 脑脊液阿尔茨海默病生物标志物阳性的PPA患者脑微出血更常见(67% vs 20%)。
  • 有和无脑叶脑微出血的患者白质高信号体积相似;PPA患者的语言和一般认知损害与脑微出血率无关。

关键数值与推荐

  • 脑微出血患病率:PPA患者28% vs 健康对照16%。
  • 脑微出血患病率:logopenic型PPA 50% vs semantic型PPA 18% vs 非流利/语法型PPA 17%。
  • 脑微出血定位:脑叶为主(81%),各PPA变异型间无差异。
  • 脑微出血患病率:脑脊液阿尔茨海默病生物标志物阳性PPA患者67% vs 阴性PPA患者20%。

临床怎么用

  • 作者认为MRI检测脑微出血有助于PPA变异型诊断,尤其是logopenic型PPA,并可提供潜在神经病理的估计。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To reveal the prevalence and localization of cerebral microbleeds (CMBs) in the 3 main variants of primary progressive aphasia (PPA) (logopenic, semantic, and nonfluent/agrammatic), to identify the relationship with underlying Alzheimer pathology, and to explore whether CMBs contribute to language breakdown. METHODS: We used a cross-sectional design in a multicenter cohort of 82 patients with PPA and 19 similarly aged healthy controls. MRI allowed for rating CMBs (2-dimensional gradient recalled echo T2*, susceptibility weighted imaging sequences) and white matter hyperintensities. CSF Alzheimer disease biomarker analyses available in 63 of the 82 patients provided the stratification of PPA into subgroups with patients who had or did not have probable underlying Alzheimer pathology. RESULTS: The prevalence of CMBs was higher in patients with PPA (28%) than in controls (16%). They were more prevalent in logopenic PPA (50%) than in semantic PPA (18%) and nonfluent/agrammatic PPA (17%). The localization of CMBs was mainly lobar (81%) with no difference between the PPA variants. CMBs were more frequent in PPA patients with positive than with negative CSF Alzheimer disease biomarkers (67% vs 20%). Patients with and without lobar CMBs had similar volumes of white matter hyperintensities. Language and general cognitive impairment in PPA was unrelated to CMB rates. CONCLUSIONS: CMB prevalence in PPA is higher than in healthy controls. CMBs were most prevalent in the logopenic variant, were related to underlying Alzheimer pathology, and did not affect the language/cognitive impairment. Our findings also suggest that CMB detection with MRI contributes to PPA variant diagnosis, especially of logopenic PPA, and provides an estimator of the underlying neuropathology.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Mendes A, Bertrand A, Lamari F, et al. Cerebral microbleeds and CSF Alzheimer biomarkers in primary progressive aphasias. Neurology. 2018. PMID: 29444966. doi:10.1212/WNL.0000000000005165

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。